Auditor General’s report says $725m in drugs still to be delivered for 2022

The Auditor General’s report for 2022 says that $725m in drugs and medical supplies were still outstanding at the end of August this year.

In the report tabled in the National Assembly yesterday, it was disclosed that the largest outstanding amounts to be delivered are from Western Scientific at $438m, New GPC Incorporated at $137m and Meditron at $100m.

The report said that in September 2023, the ministry submitted stores received and delivery notes for drugs and medical supplies valued at $133.6m. The audit office said that it is in the process of validating the deliveries.